This panel detects a broad spectrum of uropathogens and resistance genes directly from urine samples, providing providers with a comprehensive profile for personalized antimicrobial therapy.
Includes:
- coli, Klebsiella spp., Proteus spp., Enterococcus spp., Pseudomonas aeruginosa
- Resistance markers: ESBL, KPC, NDM, VRE, AmpC, and more
Benefits: - Guides appropriate antibiotic use
- Reduces unnecessary broad-spectrum prescriptions
- Results within 24–48 hours